Kellerhals Carrard advised Verity, creators of the commercially successful inventory tracking solution powered by fully autonomous indoor drones, in the completion of a USD32 million Series B funding round led by A.P. Moller Holding
Seamless Therapeutics, a German biotechnology firm, has successfully concluded a USD12.5 million Seed Financing, a university carve-out including equity financing, in-licensing of an innovative patent portfolio from Technische Universität Dresden and hiring of key
Legal advisors involved in the UBS-Credit Suisse merger: For UBS: Freshfields Bruckhaus Deringer (‘Freshfields’) is advising UBS Group as global transaction counsel. UBS counsel also include Bär & Karrer and Davis Polk. For Credit
Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis
CODE41, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus and the opensource smart contract published by
Fangda Carbon New Material Co., an integrated carbon materials producer in in the People’s Republic of China with diversified product offerings, including graphite electrodes, carbon blocks, isostatic graphite and iron ore concentrates, sold 22m
Highland Europe has announced a €1 billion fund to further support growth-stage consumer internet and software companies with roots in Europe. The firm has raised its fifth fund to help Europe’s most ambitious entrepreneurs scale
Nestlé Holdings, Inc. recently wrapped up a noteworthy financial transaction with the assistance of Homburger, a trusted legal advisor. The deal involved the issuance of a total of USD 3 billion in notes through an institutional (
The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million. The
The change management partner group (cmp) joint forces with CONSTELLATION ACADEMY (CAG), a platform company of one of the investment funds managed by CONSTELLATION CAPITAL. Cmp will continue to operate independently in the market and
